These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 14414887)

  • 1. [The Salk vaccination in the light of the follow-up in paralysis].
    LE GRAND E
    Praxis; 1959 Jul; 48():707-10. PubMed ID: 14414887
    [No Abstract]   [Full Text] [Related]  

  • 2. Poliomyelitis; effect of Salk vaccine on severity of paralysis.
    WYMAN MG; LINDGREN WD; MAGOFFIN R
    Calif Med; 1957 Jul; 87(1):1-8. PubMed ID: 13446735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demonstrations of complications in poliomyelitis vaccination and of the differential diagnosis of flaccid paralysis].
    BAUMANN T
    Schweiz Med Wochenschr; 1960 Jun; 90():623-7. PubMed ID: 13797719
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the relations between Salk vaccination and the clinical couse of poliomyelitis].
    LOSONCZY G; VIGH G; RUDNAI O; BODA D
    Munch Med Wochenschr; 1961 Aug; 103():1501-4. PubMed ID: 13763596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlation between Salk vaccination and natural history of poliomyelitis].
    LOSONCZY G; VIGH G; RUDNAI O; BODA D
    Orv Hetil; 1961 Apr; 102():733-6. PubMed ID: 13763595
    [No Abstract]   [Full Text] [Related]  

  • 6. [Formation and persistence of antibodies against poliomyelitis after vaccinations with Salk vaccine. A contribution to the value and limitations of Salk vaccinations].
    BUERGIN-WOLFF A; BERGER E
    Schweiz Med Wochenschr; 1960 Jun; 90():633-7. PubMed ID: 13805708
    [No Abstract]   [Full Text] [Related]  

  • 7. [On health disorders after poliomyelitis vaccination].
    TRUCKENBRODT H
    Z Kinderheilkd; 1962; 86():619-31. PubMed ID: 13922656
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of complement-fixing antibodies durign anti-poliomyelitis vaccination according to the Salk method].
    CASSANO A; NUZZOLO L; RAVETTA M; MARINONI G; RIZZA O; GIORDANO G
    Boll Soc Ital Biol Sper; 1960 Feb; 36():185-8. PubMed ID: 13808204
    [No Abstract]   [Full Text] [Related]  

  • 9. [On neutralizing antibodies before and after vaccination against poliomyelitis with Salk vaccine].
    GILLERT KE; GRUETZNER L; HARTMANN H
    Zentralbl Bakteriol; 1960 Feb; 177():289-98. PubMed ID: 13850076
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliomyelitis in Des Moines, Iowa, 1959. The influence of Salk vaccination on the epidemic pattern and the spread of the virus in the community.
    CHIN TD; MARINE WM; HALL EC; GRAVELLE CR; SPEERS JF
    Am J Hyg; 1961 Jul; 74():67-94. PubMed ID: 13693102
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization of infants with formalinized poliomyelitis vaccine (Salk type).
    SPIGLAND I; GOLDBLUM N
    Pediatrics; 1960 May; 25():812-21. PubMed ID: 13833339
    [No Abstract]   [Full Text] [Related]  

  • 12. The effectiveness of Salk vaccination in a Massachusetts urban area.
    BARNARD DE
    New Physician; 1962 May; 11():131-5. PubMed ID: 13865071
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reactions, complications and contraindications in the Salk antipoliomyelitis vaccination].
    MARASS I
    Inf Med; 1961 May; 16():151-5. PubMed ID: 14469554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Report on the Salk vaccine].
    VIVELL
    Monatsschr Kinderheilkd (1902); 1956 Mar; 104(3):121-8. PubMed ID: 13321822
    [No Abstract]   [Full Text] [Related]  

  • 15. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the effectiveness of Salk vaccine in Alberta with special reference to the outbreak of poliomyelitis in 1960.
    SMITH ES
    Can J Public Health; 1961 Nov; 52():467-73. PubMed ID: 13914212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations for the implementation of the Salk vaccine].
    BUSTAMANTE W
    Rev Chil Pediatr; 1956 Mar; 27(3):123-7. PubMed ID: 13350716
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactions to the salk polio vaccine injections of April 1955.
    DAVIS PL
    Med Times; 1956 Jul; 84(7):707-9. PubMed ID: 13347478
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibody response of infants to a "booster" dose of the Salk type of poliomyelitis vaccine given from 5 to 6 months after early primary immunization].
    MORRONE G; NUNZIATA B
    Pediatria (Napoli); 1961; 69():851-6. PubMed ID: 14476315
    [No Abstract]   [Full Text] [Related]  

  • 20. A community vaccination program. A report on the introduction and subsequent use of Salk polio vaccine in Omaha and Douglas County.
    LYMAN ED; ADAMS B
    Nebr State Med J; 1962 May; 47():290-6. PubMed ID: 14467569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.